Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
230
about 6.1 years
56–85
1 site in IA
What this study is about
This trial is testing whether a treatment of 5mg melatonin improves Alzheimer's disease biomarkers and cognitive function in older adults. Participants will have blood draws to measure biomarkers, and their cognitive function will be assessed with tests. The lumbar puncture procedures for this clinical trial have been eliminated.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Melatonin
- 2.Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
melatonin (Hormone supplement; regulates sleep-wake cycle)
oral (Disintegrating Oral Tablet)
Secondary: Sleep Efficiency
Neurology